By Dr. Olexandr Isayev, Ph.D. Associate Professor, Carnegie Mellon University Machine learned interatomic potentials (MLIPs) are reshaping computational chemistry practices because of their ability to drastically exceed the...
Olexandr Isayev is an Associate Professor at the Department of Chemistry at Carnegie Mellon University. In 2008, Olexandr received his Ph.D. in computational chemistry. He was a Postdoctoral Research Fellow at Case...
By Dr. Daniela Blanco, Ph.D., CEO and Co-Founder, Sunthetics Pharmaceutical crystallizations, as well as process and product development present significant challenges in terms of cost, efficiency, and sustainability. Harnessing...
By Dr. Jeremy M. Merritt, Ph.D. Senior director and Group leader, Eli Lilly & Co. Automation plays a vital role in reducing development time in the pharmaceutical industry, both...
Jeremy M. Merritt (merrittje@lilly.com) is currently a Senior director and group leader at Eli Lilly and Co. in the synthetic molecule design and development organization (SMDD). He joined Lilly...
By Dr. Gerard Capellades, Assistant Professor, Rowan University Industrial crystallization is heavily used as a purification step and to isolate valuable products with the desired solid-state properties. Consequently,...
Gerard Capellades is an Assistant Professor at Rowan University’s Department of Chemical Engineering. He has worked on crystallization as his primary research field for the past 12 years, always...
